CLSI C52-A2

Toxicology and Drug Testing in the Clinical Laboratory; Approved Guideline, Second Edition, C52A2E

Clinical and Laboratory Standards Institute, 04/01/2007

Publisher: CLSI

File Format: PDF

$143.00$287.20

Description

Published:01/04/2007

Pages:68

This guideline addresses drug testing in the clinical laboratory, both for clinical and forensic purposes, and pertains to both drugs of abuse and other drugs normally encountered and analyzed by hospital laboratories.

The guideline discusses the preanalytical, analytical, and postanalytical considerations for specimen collection, methods of analysis, quality assurance, and the reporting and interpretation of results.

More CLSI standard pdf

CLSI M52 (R2020)

Verification of Commercial Microbial Identification and Antimicrobial Susceptibility Testing Systems, M52Ed1E

$90.00 $180.00

CLSI MM21 (R2020)

Genomic Copy Number Microarrays for Constitutional Genetic and Oncology Applications, 1st Edition, MM21Ed1E

$90.00 $180.00

CLSI EP36-Ed1

Harmonization of Symbology and Equations, 1st Edition, EP36Ed1E

$148.00 $297.67

CLSI VET01-A4 and VET01-S3

Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacterial Isolated from Animals; Approved Standard-Fourth Edition and Supplement, VET01A4E and VET01S3E

$90.00 $180.00